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A common problem with the controlled expression of foreign
DNA in eukaryotic cells is a high level of basal activ ity. Here
we report that a series of mutations in the AP- 1 binding site of
the human metallothionein IIA (hMTIIA) promoter drastically
reduces the basal level of expression but still allows
hyperinduction upon treatment with exogenous factors, e.g. heavy
metal ions and the tumor promoter 4-beta-phorbol 12-myristate
13-acetate (PMA).
A fragment of the hMTIIA promoter (-302 to + 73) was used
to obtain two constructs, pMT302CAT and pMT302,ACAT. with
the chloramphenicol acetyltransferase (CAT) as a reporter gene.
pMT302CAT with an intact AP- 1 site was obtained by subcloning
the 693 bp PstI/NcoI fragment of hMTIIA from pHSI (I) into
the Pstl/BamHI digested vector pBLCAT5 (2), leading to the
construct pMT620CAT. The NcoI and BamHI sites were blunted
with Klenow polymerase prior to ligation. The HgiAI/XhoI
fragment of this construct, containing the hMTIIA sequence firom
-302 to +73, was subcloned into PstI/XhoI digested
pMT620CAT. The AP- 1 site was mutated in the pMT302ACAT
from GTGACTCAG to GTGTCTAGA (-105 to -97.
substituted bases in bold) by hybridizing the oligonucleotide 5'-A-
GCCGCAAGTGTCTAGACGCGGGGCGT-3' to the hMTIIA
promoter between pos. - 113 and -87. following a previously
described technique (3).
The HeLa cells (American Type Culture Collection, ATCC)
were co-transfected using the Ca' + phosphate precipitation
method (4) with 10 ,ug of CAT construct and 2 ,tg of 3-
galactosidase expressing vector pCHl 10 (Pharmacia) in order
to normalize transfection efficiencv. Cells were maintaiined in
DMEM supplemented with 10% fetal calf serum (FCS) and
antibiotics. Twelve hours after transfection cells were starved
tor 24 h, followed by stimulation with PMA (100 ng/ml) or
ZnCl, (100 jxM) for 40 h in serum-free media. Cells were
harvested and protein concentrations, CAT and 3-galactosidase
activities were determined as described (5).
pMT302CAT showed significant level of CAT activity even
in the absence of exogenous stimulation (Fig. 1A. left panel).
In contrast, the pMT302ACAT did not express any detectable
CAT activity in the absence of Zn', PMA (Fig. IA. right
panel). The induced CAT activ ities of pMT302ACAT, however.
were lower than those of pMT302CAT (29.5 vs. 53.9 fotr the
PMA and 46.3 vs. 63.3 for Zn->).
To further document the mutated promnoter. hun1an
lyrmphoblastoma CCRF-CEM cells (ATCC) and ai primnary
culture of human endometrial stromal cells were transfected with
pMT302ACAT. CCRF-CEM and endometrial stromal cells Were
grown in RPMI 1640 media supplenmented with 10V% dialyzed
Figure 1. Nlutated pMT1302-CAT is silcnit and hyperinclucihle in transicritl
transfected cells. CAT assays were pertormnCd Lusin"l thin-las r chritnatograph\
and Visualized hv autoradography. lUpper panel: X. ExptldssiOi 01 wt
pMT302CAT and miiutatcd pMT302-CAT in HeLa cells stilltil ited wsith cither
1l(X) ji ZnCI,. I(X) ng, ml PNIA (o with hottl het imou.n11OL111t Of CCII CX\tlract
per lane was niormaLilized lor ;3-ealactosidase activitv. CAT activ ity %\k1s detcrimitni.ed
bv densitomnetrs Co.: conitrol cells without StillILrwitioto. Bottom panel: Expression
Of pMIT302-ACAT in endometrial strormal cells (B) aind in CCRF-CENI cells (C).
Cells werc stimulated with indicated coniceintrations ol ZnCI,. CAT tilts %its "ais
meaIsured uLsine ANIBIS radioimiaege analsscr (AMNIBIS) and notrtit ith/ d tor 3-
-alactosidasc activity.
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Figure 2. Protein expression in CCRF-CEM cells stably transfected with
pMT302AicIL-lra. Two clones were stimulated for 24 h with or without 100
ttM ZnCl,. Cell lysates (105 cells/lane) and human recombinant icIL-Ira were
resolved on 15% SDS/PAGE, blotted and detected with affnity-purified polyclonal
rabbit anti-icIL-lra primary antibodies (6).
FCS and antibiotics. Cells were electroporated at a density of
107 cells/ml using GenePulser (Bio-Rad) at U = 500 V/cm, t
= 23 ms. and U = 570 V/cm, t = 21 ms. for endometrial
stromal cells and CCRF-CEM cells, respectively. Plasmids
pMT302ACAT (40 ,ug/ml) and pCH110 (20,Ig/ml) were added
to the cells prior to electroporation. Twenty-four hours after
electroporation, cells were stimulated with the indicated
concentrations (Fig. 1B, C) of ZnCl2 for 48 h, harvested and
processed as above. In both CCRF-CEM (Fig. iB) and
endometrial stromal cells (Fig. IC) the pMT302ACAT showed
low basal activity and high CAT induction after Zn2+ treatment.
The ratio of the Zn2+-inducible to basal expression was as high
as 35.7 in CEM cells (Zn2+ = 200 ,tM) and 13.7 in human
endometrial stromal cells (Zn2+ = 100u/M).
In an additional experiment, CCRF-CEM cells were stably
transfected with an expression vector containing cDNA for the
intracellular interleukin receptor antagonist (icIL- ira) under
control of the mutated hMTIIA promoter. The 680 bp
XhoI/BamHI fragment containing the complete open reading
frame of the icIL-Ira cDNA (6) was blunted at the BamHI site
using Klenow polymerase and subcloned into SmaI/XhoI digested
pMT302ACAT vector. The pcDNAINeo vector (Invitrogen) was
used for co-transfection with the pMT302zAicIL- Ira for selection
of stably transfected clones. Cells were electroporated as above,
maintained in media with a dialyzed serum and selected in
geneticin (Gibco BRL) at a final concentration of 1.2 mg/mi.
Single clones were established following limiting dilution.
Expression of the icIL- 1ra protein was detected using Western
blot analysis. We demonstrate that in the absence of Zn2+ these
cells did not produce a detectable amount of icIL-Ira protein,
but stimulation resulted in a high level of icIL- Ira expression
(Fig. 2).
Our results indicate that the mutation of the AP- 1 binding site
does not interfere with the PMA induction of the hMT302A
promoter. This contradicts a report identifying the AP- 1 binding
site in hMTIIA as the PMA responsive element (7). It supports,
however, observations on AP- 1 binding in PMA inducible
metalloproteinase genes, collagenase I and stromelysin. PMA
induction of these promoters was initially thought to be mediated
by AP- I site binding (8,9), but later reports suggested a role for
AP-l only in maintaining basal activity (10,11). In contrast to
the metalloproteinase promoters which were found completely
inactive upon mutation of their AP- 1 binding sites (9), hMT302A
still showed hyperinducibility with PMA or heavy metal ions.
The mutated human metallothionein promoter, therefore, could
be a versatile tool for studies in which a tight control of exogenous
gene products is essential.
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